Journal article
18 Oral Recommendations from the European Commission Initiative on Breast Cancer on multigene tests to guide the use of adjuvant chemotherapy in patients who have hormone receptor positive, HER-2 negative, lymph node negative or up to 3 lymph nodes positive invasive breast cancer
Authors
Rossi PG; Lebeau A; Canelo-Aybar C; Rivera MCP; Comas DR; Quinn C; Coello PA; McGarrigle H; Warman S; Broeders M
Journal
European Journal of Cancer, Vol. 138, , pp. s12–s13
Publisher
Elsevier
Publication Date
October 2020
DOI
10.1016/s0959-8049(20)30555-4
ISSN
0959-8049